Adagio Medical Holdings (ADGM) Invested Capital (2023)

Adagio Medical Holdings (ADGM) reported Invested Capital of $1.7 million for Q4 2023.

Adagio Medical Holdings (ADGM) Invested Capital (2023) Analysis & Trends

Adagio Medical Holdings (ADGM) has 1 years of Invested Capital data on file, last reported at $1.7 million in Q4 2023.

For the quarter ending Q4 2023, Invested Capital changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Sep 2024 stood at $1.7 million (changed N/A YoY), and the FY2023 full-year result was $1.7 million, changed N/A from the prior year.
Invested Capital held at $1.7 million in Q4 2023.
In the past five years, Invested Capital ranged from a high of $1.7 million in Q4 2023 to a low of $1.7 million in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	4.41 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	499.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	41.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	1.41 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	7.00 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	15.00 Mn
10	Adagio Medical Holdings	21.49 Mn	21.49 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	1.70 Mn